Skip to main content

Day: January 7, 2021

Offer Update

HARGREAVE HALE AIM VCT PLCLEI: 213800LRYA19A69SIT31   7 January 2021Announcement of Intention to Utilise Over-Allotment Facility and Offer UpdateOn 2 September 2020, Hargreave Hale AIM VCT plc (the “Company”) launched an offer for subscription to raise up to £20 million, together with an over-allotment facility of up to a further £10 million (the “Offer“). Full details of the Offer are contained in a prospectus (the “Prospectus“), which was published by the Company on 2 September 2020.Under the terms and conditions of the Offer, as set out in the Prospectus, the directors of the Company have the ability (at their discretion), to increase the number of Shares available for subscription to raise further amounts under the Offer of up to £10 million.The Company has received valid applications in excess of £19 million and, accordingly,...

Continue reading

Dividend Declaration – Correction

HARGREAVE HALE AIM VCT PLC(the Company)7 January 2021Correction: Record Date for DividendCorrection to the announcement made at 08.23 on 22 December 2020: The last date for receipt of elections in respect of the Dividend Re-investment scheme (DRIS) is 28 January 2021 and not 22 January 2021 as previously announced. The full corrected announcement is as per below,  all other information was correct:Record Date for DividendFurther to the announcement of the Annual Report and Accounts of the Company for the year ended 30 September 2020, subject to approval at the AGM, the record date for the 2.65p final dividend per ordinary share will be 8 January 2021, the corresponding ex-dividend date will be 7 January 2021 and the payment date will be 11 February 2021.The last date for receipt of elections in respect of the Dividend Re-investment scheme...

Continue reading

Global Bioenergies : extension de la ligne de financement en fonds propres avec Kepler Cheuvreux

Global Bioenergies : extension de la ligne de financement en fonds propres avec Kepler CheuvreuxEvry, le 07 janvier 2021 – Global Bioenergies (ALGBE) annonce l’exercice intégral des 1.500.000 bons de souscription d’actions (BSA I) émis dans le cadre de la ligne de financement mise en place le 25 août dernier avec l’entreprise d’investissement Kepler Cheuvreux agissant en qualité d’intermédiaire financier. L’exercice de ces bons a permis de lever un peu plus de 6,5 millions d’euros.Samuel Dubruque, Directeur administratif et financier de Global Bioenergies, commente : « Cette ligne de financement a fonctionné à un rythme plus rapide qu’escompté, bénéficiant de conditions de marché favorables. Elle n’a représenté que 7,5% des échanges sur la période et n’a donc pas empêché l’évolution haussière du cours, lequel a plus que doublé depuis...

Continue reading

More Verizon customers in more places get access to 5G on their phone and in their home

What you need to know:Verizon 5G Home Internet to expand to parts of six new markets: Arlington, TX; Miami, FL; Anaheim, CA; Phoenix, AZ; San Francisco, CA and St. Louis, MO.Customers will now have access to Verizon’s 5G Ultra Wideband service in Colorado Springs, CO; Columbia, SC and Knoxville, TN.Verizon’s Nationwide 5G service, built with the most advanced technology available in the industry, is available for 230 million people in 2,700 US cities5G Home and wireless customers can get up to 12 months of the brand new discovery+ streaming service.Verizon Chairman and CEO Hans Vestberg to deliver the kickoff keynote for CES 2021 on Monday January 11.BASKING RIDGE, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) — Verizon today announced more 5G for all. Customers who received access to Verizon’s Nationwide 5G service last year, built with...

Continue reading

Adverum Biotechnologies Announces New GMP Gene Therapy Manufacturing Facility

— 174,000-square-foot commercial GMP facility in Durham, NC for the manufacturing of ADVM-022, an intravitreal gene therapy in development for wet AMD and DME —— Multiple production suites with total capacity of 4000L, with further expansion opportunities —— Adverum to invest over $80M to be production-ready by end of 2023 and create more than 200 life sciences jobs; Company to receive state and local incentives of up to $9M —REDWOOD CITY, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced plans for a new Good Manufacturing Practices facility in Durham, North Carolina. Adverum will invest over $80 million in the 174,000-square-foot facility, located...

Continue reading

BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE DES CCI CA SUD RHONE ALPES POUR LA PERIODE DU 2nd SEMESTRE 2020

CAISSE REGIONALE DE CREDIT AGRICOLE MUTUEL SUD RHONE ALPESSOCIETE COOPERATIVE à CAPITAL VARIABLESiège social : 12 place de la Résistance, CS20067 – 38041 Grenoble Cedex 9402 121 958 RCS GrenobleGrenoble, le 6 janvier 2021Bilan semestriel du contrat de liquidité de la société CR CA SUD RHONE ALPESAu titre du contrat de liquidité confié par la société CR CA SUD RHONE ALPES à Kepler Cheuvreux, à la date du 31 décembre 2020, les moyens suivants figuraient au compte de liquidité :–   5 185 titres–   717 569.34 € en espèces–    Nombre de transactions exécutées sur le semestre à l’achat : 257–    Nombre de transactions exécutées sur le semestre à la vente : 246–    Volume échangé sur le semestre à l’achat : 2 498 titres pour 377 872.29 €–    Volume échangé sur le semestre à la vente : 2 062...

Continue reading

Albioma : Half-year statement of the liquidity contract as at 31 December 2020

Press releaseParis La Défense, 7 January 2021Half-year statement of the liquidity contractAs at 31 December 2020Regarding the liquidity contract managed by Rothschild Martin Maurel, Albioma announces that the liquidity account contained the following assets as at 31 December 2020:0 share;€3,042,035.Detailed information on the number of transactions carried out and the volume traded, in terms of sales and purchases, during the past half year is available on the company’s website, www.albioma.com.As a reminder, the previous half-year statement of the liquidity contract as at 30 June 2020 showed that the liquidity account contained the following assets:281 shares;€3,008,689.AttachmentAlbioma_CP_20210107_ENG

Continue reading

ALBIOMA : Bilan semestriel du contrat de liquidité au 31 décembre 2020

Communiqué de presseParis La Défense, le 7 janvier 2021Bilan semestriel du contrat de liquiditéAu 31 décembre 2020Dans le cadre du contrat de liquidité opéré par Rothschild Martin Maurel, Albioma annonce que les moyens suivants figuraient au compte de liquidité en date du 31 décembre 2020 :0 action ;3 042 035 euros.Les informations détaillées relatives au nombre de transactions exécutées à l’achat et à la vente et au volume échangé à l’achat et à la vente au cours du semestre écoulé sont disponibles sur le site Internet de la Société, www.albioma.com.Il est rappelé que lors du dernier bilan semestriel au 30 juin 2020, les moyens suivants figuraient au compte de liquidité :281 actions ;3 008 689 euros.Pièce jointeAlbioma_CP_20210107

Continue reading

Rackspace Technology Named a Major Player in IDC MarketScape: Applications Management Services on the Cloud 2020 Vendor Assessment

SAN ANTONIO, Jan. 07, 2021 (GLOBE NEWSWIRE) — Rackspace Technology™ (NASDAQ: RXT), a leading end-to-end multicloud technology solutions company, today announced it has been positioned in the Major Players category in the IDC MarketScape: Worldwide Application Management Services on the Cloud 2020 Vendor Assessment (doc # US46924517, November 2020). The inaugural IDC MarketScape assesses 13 qualifying organizations on their Application Management (AM) offerings and performance in the cloud market based on market demands and expected buyer needs.Positioning Rackspace Technology in the Major Players Category results from implementing a comprehensive approach developing customized plans to align with customers’ primary business objectives. Customers are supported through full-service expert AM, including configuration, data services,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.